Vulvar yolk sac tumor mixed with embryonal carcinoma in a peri-pubertal girl: A case report

详细信息    查看全文

• 作者：Cherry Yin-Yi Chang^a ; ^d ; ^e ; Kang-Hsi Wu^c ; Tze-Yi Lin^b ; ^e ; Wei-Chun Chang^a ; ^d ; Wu-Chou Lin^a ; ^d ; Yao-Ching Hung^a ; ^d ; Lian-Shung Yeh^a ; ^d ; ^{lsyeh@mail.cmuh.org.tw}
• 关键词：Embryonal carcinoma ; Peripheral blood stem cell transplantation ; Vulvar mass ; Yolk sac tumor
• 刊名：Taiwanese Journal of Obstetrics and Gynecology
• 出版年：2011
• 出版时间：December 2011
• 年：2011
• 卷：50
• 期：4
• 页码：503-505
• 全文大小：1260 K

文摘

Objective

Vulvar cancer is rare in Eastern females, especially in pre- and peripubertal girls. The prognosis of vulvar cancer is poor and treatment is variable.

Case Report

A 14-year-old girl suffered from a left vulvar tenderness mass and underwent excision of the mass. The diagnosis of the pathology was vulvar yolk tumor with an embryonal carcinoma. After the vulvectomy, inguinal area lymph node dissection, chemotherapy (bleomycin, etoposide and cisplatin) treatment and radiotherapy, metastasis to lung was also noted after eight months. Resection of lung tumor was performed. She received chemotherapy with a combination of paclitaxel, ifosphamide and cisplatin (TIP) and received peripheral blood stem cell transplantation (PBSCT) twice and chemotherapy treatment of gemitabine and oxaliplatin (GEMOX). Up until now, the patient has been free of disease.

Conclusion

High-dose TIP and GEMOX chemotherapy plus PBSCT for bone marrow rescues could be considered to treat patients with metastatic malignant vulvar germ cell tumor after failed first-line chemotherapy and radiation.